Position in WVE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,401,481
-$176,481 QoQ
Shares Held
585,453
+18.6% QoQ
Ownership
0.297%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#48
of 237 holders
Holding Since
Sep 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WVE Over Time
Shares Held
Position Value (USD)
Derivatives in WVE
reported options exposure · as of Jun 30, 2026CallValue
$274,813
CallShares
47,300
PutValue
$54,614
PutShares
9,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. WVE ranks #34 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in WVE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,614 | 9,400 | Put | Sole | 2026-08-03 | |
| 2026-06-30 | $274,813 | 47,300 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $3,401,481 | 585,453 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $203,725 | 28,100 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $86,275 | 11,900 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $3,577,962 | 493,512 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $289,000 | 17,000 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $6,439,991 | 378,823 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $103,700 | 6,100 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $5,348,277 | 730,639 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $25,620 | 3,500 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $138,348 | 18,900 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $21,450 | 3,300 | Put | Sole | 2025-08-13 | |
| 2025-06-30 | $124,800 | 19,200 | Call | Sole | 2025-08-13 | |
| 2025-06-30 | $3,041,265 | 467,887 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,157,987 | 390,840 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $4,848 | 600 | Call | Sole | 2025-05-14 | |
| 2024-12-31 | $6,515,254 | 526,698 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,940,016 | 602,441 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $340,145 | 55,129 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,186,311 | 432,933 | Shares | Sole | 2024-02-14 | |
| 2022-12-31 | $602,182 | 86,026 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,449,415 | 401,500 | Shares | Sole | 2022-11-14 | |
| 2020-12-31 | $1,226,193 | 155,806 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,673,429 | 197,106 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||